The global tomosynthesis market is expected to reach $5.50 Billion by 2030, according to a new report published by The Brainy Insights. The market is expected to witness a CAGR of 10.8% from 2021-2030.
Tomosynthesis is a type of imaging technique used in medical diagnosis for the detection of various diseases and abnormalities. It is an imaging technology that produces 3-dimensional images of the target area by combining multiple 2-dimensional images acquired at different angles. Tomosynthesis is used to create a virtual slice of a target area that allows better visualization of the internal organs and tissues.
The increasing prevalence of chronic diseases such as cancer and cardiovascular diseases, coupled with technological advancements, is expected to drive market growth. Moreover, increasing investment in the development of tomosynthesis systems by major key players is likely to fuel market growth. For instance, in November 2019, Siemens Healthineers acquired Corindus Vascular Robotics, Inc., a manufacturer of robotic-assisted coronary and peripheral intervention systems.
The rising geriatric population, coupled with the growing prevalence of chronic diseases, is likely to boost the demand for tomosynthesis systems. Moreover, the increasing adoption of tomosynthesis systems in the diagnosis of breast, lung, and other cancers is expected to propel market growth.
The 3D tomosynthesis segment is expected to register the highest CAGR from 2021 to 2030. This is attributed to the increasing adoption of 3D tomosynthesis systems for the diagnosis of breast cancers. 3D tomosynthesis systems provide improved imaging quality and improved detection of cancerous lesions and microcalcifications.
North America is expected to dominate the tomosynthesis market and is anticipated to retain its dominance over the forecast period. This is attributed to the rising prevalence of chronic diseases, increasing demand for early diagnosis of breast cancer, and the presence of major players in the region.
Restraints of the Tomosynthesis Market
The major restraining factors of the tomosynthesis market are the high cost associated with the implementation of the tomosynthesis technology in existing healthcare facilities and the lack of trained personnel to interpret the tomosynthesis images.
Opportunities in the Tomosynthesis Market
The global tomosynthesis market is expected to witness significant growth in the coming years due to the increasing awareness of the benefits of tomosynthesis to diagnose diseases, increasing research and development activities, and the increasing adoption of tomosynthesis imaging systems. The market is expected to be driven by the increasing demand for the early detection of breast cancer, which will result in the increased demand for tomosynthesis imaging systems. In addition, the development of advanced tomosynthesis imaging systems that provide more accurate results is expected to further fuel the growth of the tomosynthesis market.
Key Players
The major players operating in the global tomosynthesis market are GE Healthcare, Hologic, Inc., Siemens Healthineers, CMR Naviscan Corporation, FUJIFILM SonoSite, Inc., Konica Minolta, Inc., Canon Medical Systems Corporation, Carestream Health, and Koninklijke Philips N.V.
Get a comprehensive report summary that describes the market value and forecast along with the research methodology. Download the PDF brochure
